GSK Says US FDA Approved Its Twice-Annual Asthma Drug Exdensur

GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.

By Ashleigh Furlong · Bloomberg

GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.